A discounted cash flow analysis suggests Westinghouse Air Brake Technologies (Wabtec) shares may be trading at a premium. We break down the valuation model, its assumptions, and the broader market forces at play for the rail equipment leader.
A wave of insider selling at The Progressive Corporation, totaling over $16 million in the past year, has prompted investors to scrutinize the insurer's outlook. While such sales aren't uncommon, the scale and timing invite questions about internal confidence as the stock trades significantly below recent insider sale prices.
As Entergy Corporation (NYSE: ETR) carries a substantial $28.9 billion in net debt, analysts are scrutinizing whether the utility's growth strategy has overleveraged the company, raising questions about risk and long-term shareholder value.
The European Union's impending ban on Russian liquefied natural gas imports is poised to trigger orders for at least 30 new LNG tankers, as the bloc scrambles to reconfigure its energy supply chains ahead of key 2026-2027 deadlines.
The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.
After a prolonged period of U.S. dominance, international equities are staging a comeback. Analysts point to shifting fundamentals, attractive valuations, and a weakening dollar as tailwinds for emerging markets, with one Vanguard ETF positioned at the center of this transition.
A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
The United States' formal exit from the World Health Organization, effective January 2026, may not trigger immediate changes, but experts warn it could gradually reshape the landscape of healthcare expenses for millions of Americans.
Amgen has transferred full rights for the atopic dermatitis drug rocatinlimab back to Kyowa Kirin, clearing the path for the Japanese firm to pursue US approval by 2026. The move comes despite the drug meeting all trial endpoints, reflecting Amgen's portfolio reprioritization and a tempered market outlook for the OX40 inhibitor class.
A stark consensus is emerging among prediction market traders and analysts, with a 71% probability now priced in for Bitcoin to fall below $65,000 within two years. This bearish outlook follows a weekend sell-off to nine-month lows and is supported by underwater ETF positions, technical warnings, and concerns over a sustained market downturn rather than a temporary correction.
South Korean financial regulators are deploying advanced artificial intelligence to monitor cryptocurrency transactions in real-time, aiming to detect and preempt market manipulation. The move, part of a broader crackdown, could see violators face severe penalties, including life imprisonment.
Cleveland-based KeyCorp (KEY) is riding a wave of positive analyst sentiment following a strong earnings beat, with its stock performance significantly outpacing broader market indices. The bank's diversified model and robust capital returns are fueling optimism for sustained growth.
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Analyst Joe Laetsch raises HF Sinclair's price target, highlighting favorable crude differentials and a recent $38 million acquisition aimed at expanding its lubricants business, as the refiner lands on a list of top low-risk dividend stocks.
Seaport Research analyst Scott Graham lowered Badger Meter's price target to $220 from $255, citing a slower sales pace in early 2025. The firm maintains a Buy rating, anticipating a stronger second half. The water technology company recently reported record annual sales and profits.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
Insurance brokerage giant Arthur J. Gallagher reported robust fourth-quarter profit growth, driven by resilient demand. However, Truist Securities has lowered its price target on the stock, citing valuation pressures across the property & casualty brokerage sector.
Barclays raises its price target on NorthWestern Energy Group (NWE) to $62, citing solid quarterly performance and strategic moves, including a pending merger with Black Hills Corporation, as the regulated utility reaffirms its long-term growth outlook.
